This is how absurd this market is. Their pps was sitting at 9.13 and they released news that their Testosterone product had 'good' top line results from a 'clinical trial.' Their product is not yet FDA approved, and it will compete with 3 other products in the market already, if and when approved. The total market is estimated at roughly $2B of which they are looking for $500M or 1/4 of the market when commercialized. Also, this is not a product which can save lives or alter a major health issue in the world - it treats a condition.
So . . . maybe this is all justified by only having 18M OS.